DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection. (NCT07717437)
🩺 Plain-English Summary (8th-Grade Level)
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.
Who can join: Review the eligibility criteria below.
Location: Rush University Medical Center — Chicago, Illinois
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (31 Sites)
Showing the first 25 of 31 sites.
- Rush University Medical Center — Chicago, Illinois
- Mayo Clinic — Rochester, Minnesota
- Cleveland Clinic — Cleveland, Ohio
- Monash Medical Centre — Clayton, Victoria
- MedUni Wien — Vienna, State of Vienna
- Social Center South (Klinik Favoriten) — Vienna, State of Vienna
- UZ Antwerpen — Edegem, Antwerpen
- Erasmus Hospital — Anderlecht, Brussels Capital
- CHU de Liège — Liège, Liège
- UZ Gent — Ghent, Oost-Vlaanderen
- Juravinski Hospital and Cancer Centre — Hamilton, Ontario
- The Ottawa Hospital — Ottawa, Ontario
- McGill University Health Centre — Montreal, Quebec
- University Hospital Aachen (Uniklinik RWTH Aachen) — Aachen, North Rhine-Westphalia
- Klinikum Saarbrücken — Saarbrücken, Saarland
- Universitätsklinikum Halle — Halle, Saxony-Anhalt
- MUMC+ — Maastricht, Limburg
- Amsterdam UMC — Amsterdam, North Holland
- Universitair Medisch Centrum Groningen — Groningen, Provincie Groningen
- Leids Universitair Medisch Centrum — Leiden, South Holland
- Erasmus MC — Rotterdam, South Holland
- Auckland City Hospital — Grafton, Auckland
- Oslo University Hospital — Oslo, Oslo
- Hospital Universitari Germans Trias i Pujol — Badalona, Barcelona
- Vall d'Hebron University Hospital — Barcelona, Barcelona
📞 Contact the Study Coordinator
Phone: +316 40911632
Email: fenna.van.der.zijden@mumc.nl
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Liver Cancer
- Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) — Houston, Texas
- TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning — Houston, Texas
- Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome — New York, New York
- Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection — Basking Ridge, New Jersey
- Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors — Houston, Texas
- HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer — The Bronx, New York
Explore by condition: All Liver Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.